What drugs does CARWIN PHARM ASSOC make?

CARWIN PHARM ASSOC has 2 FDA-approved drugs including VYSCOXA, CLOTIC.

What therapeutic areas does CARWIN PHARM ASSOC focus on?

CARWIN PHARM ASSOC focuses primarily on Immunology.

← Back

Data updated: Mar 29, 2026

CARWIN PHARM ASSOC

Immunology

Pharma

CARWIN PHARM ASSOC is a pharmaceutical company focused on Immunology. Key products include VYSCOXA.

2025

Since

Drugs

Trials

Approved (2yr)

Key Drugs

VYSCOXA

celecoxib

Immunology

COX-2 4 indications · 2025

CLOTIC

clotrimazole

3 indications · 2025

Top Drug Revenues ProEarly access

Revenue Over Time ProEarly access

Recent Activity

CLOTIC 2025-09-26

Type 3 - New Dosage Form

VYSCOXA 2025-07-29

Type 3 - New Dosage Form

SEC Filings ProEarly access

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Immunology 100%

1 drugs

Pipeline Forecast

Upcoming Trial Milestones ProEarly access

Patent Cliff ProEarly access

Competitors by Therapeutic Area

Johnson & Johnson big-pharma

Immunology

CARWIN PHARM ASSOC

Key Drugs

Top Drug Revenues ProEarly access

Revenue Over Time ProEarly access

Recent Activity

Therapeutic Areas

Pipeline Forecast

Upcoming Trial Milestones ProEarly access

Patent Cliff ProEarly access

Competitors by Therapeutic Area

All Drugs (2)

Active (2)

Discontinued (0)

Company Info

CARWIN PHARM ASSOC

Set Alert

Key Drugs

Top Drug Revenues ProEarly access

Revenue Over Time ProEarly access

Recent Activity

Therapeutic Areas

Pipeline Forecast

Upcoming Trial Milestones ProEarly access

Patent Cliff ProEarly access

Competitors by Therapeutic Area

All Drugs (2)

Active (2)

Discontinued (0)

Company Info